7 results
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
clotting #INR #heparin ... #LMWH #NOAC #warfarin ... #coumadin #rivaroxaban ... apixaban #Eliquis #dabigatran
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Agents - Warfarin (Coumadin ... PCC (Kcentra) - Heparin ... /LMWH → Protamine ... sulfate - Dabigatran ... #noac #pharmacology
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
, LMWH, or fondaparinux ... (LMWH): Functions ... #LMWH #UFH #DOAC ... #Dabigatran #Apixaban ... #Fondaparinux #NOAC
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Molecular Weight Heparin ... (LMWH) - Enoxaparin ... ) inhibitors - Dabigatran ... #medications #doac
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
thrombosis in cancer ... initiated after a LMWH ... ¥LMWH is currently ... low-molecular-weight heparin ... #Cancer #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... filtration rate; DOAC ... anticoagulant; LMWH ... molecular weight heparin ... #Cancer #Algorithm
Algorithm for the diagnosis and management of iliofemoral deep vein thrombosis (DVT). In the absence of
Algorithm for the ... CAT = cancer-associated ... inferior vena cava, LMWH ... low-molecular-weight heparin ... unfractionated heparin